Biotech AI Watch
Biotech AI Watch is a source-dated public intelligence site tracking AI in biotechnology, AI medicine, drug discovery, longevity, genetics, clinical trials, biomedical research, and AI-for-science.
Biotech AI Watch is a source-dated public intelligence site for AI medicine, biotechnology, drug discovery, longevity, genetics, clinical trials, biomedical research, and AI-for-science. It keeps the starter-template posture while beginning to present a biotech AI identity.
A source publication date is the date provided by the original source, feed, or page. Ingestion time is not the same as publication time, and the site must not fake freshness or generate fake dates. When metadata is limited, the product should be honest about that limit.
Home frames the Biotech AI Watch dashboard. AI Biotech News is a chronological source-dated feed for AI medicine, biotechnology, drug discovery, clinical trials, genomics, longevity, and biomedical research. Models & Bio Tools covers biology foundation models, protein/RNA/DNA models, drug discovery platforms, lab automation tools, biomedical datasets, benchmarks, and research tools. Bio AI Agents covers agentic biomedical workflows. Research & Methodology covers biomedical AI research, AI-for-science methods, benchmarks, evaluation, safety, validation, source policy, and editorial methodology. Operator pages are diagnostics only, not public editorial content.
Biotech AI Watch focuses on public signals in AI medicine, biotechnology, drug discovery, longevity, genetics, clinical trials, biomedical research, and AI-for-science. Coverage is selective and should not be read as complete, clinical guidance, investment advice, or real-time monitoring.
Card images are illustrative. They may not depict the exact company, person, product, event, or article; they provide thematic visual context for the briefing surface.
The product remains a reusable Next.js starter-template. Existing Cloudflare, D1, scheduled ingestion, and operator diagnostic references describe the inherited architecture and are not changed by this identity copy pass.
Source coverage is curated but incomplete, metadata quality varies by source, RU localization may be limited by available localized title and summary data, images are illustrative, public selection is intentionally conservative, and the platform is still evolving.